Investor Presentaiton
Protected market leadership in aseptic processing underpinned
by high entry barriers and significant switching costs
Market entry barriers
SKAN's value proposition
Market leadership
Technological edge
Stringent regulatory
environment
Mission criticality of
aseptic processes
Lock-in effect
Mastery of difficult to replicate know-
how on highest-performance isolators
Process warranty regarding all
regulatory (e.g. FDA, EMA, Swissmedic)
required qualifications & timeline
Swiss brand, engineering & reputation
provide trust in isolator safety
Large installed base of isolators and leading
global services incl. tech transfer &
consumables across product lifecycle
November 2023
SKAN Group AG Investor Presentation
Z
OPTIMA
REINRAUMTECHNIK
IMA
SPA
Skan
SYNTEGON
PROCESSING & PACKAGING
La Calhène
vanr
Pharmasystems Inc.
11
SKANView entire presentation